Department of Pharmaceutical/Medicinal Chemistry II, University of Regensburg, Regensburg, Germany.
Faculty of Chemistry/Pharmacy, University of Regensburg, Regensburg, Germany.
Trends Pharmacol Sci. 2017 Aug;38(8):717-732. doi: 10.1016/j.tips.2017.05.005. Epub 2017 Jun 20.
Previously, drugs were developed focusing on target affinity and selectivity. However, it is becoming evident that the drug-target residence time, related to the off-rate, is an important parameter for successful drug development. The residence time influences both the on-rate and overall effectiveness of drugs. Furthermore, ligand binding is now appreciated to be a multistep process because metastable and/or intermediate binding sites in the extracellular region have been identified. In this review, we summarize experimental ligand-binding data for G-protein-coupled receptors (GPCRs), and their binding pathways, analyzed by molecular dynamics (MD). The kinetics of drug binding to GPCRs are complex and depend on several factors, including charge distribution on the receptor surface, ligand-receptor interactions in the binding channel and the binding site, or solvation.
以前,药物的研发主要集中在靶点亲和力和选择性上。然而,现在越来越明显的是,药物-靶点的居留时间(与解离速率相关)是药物研发成功的一个重要参数。居留时间会影响药物的结合速率和整体效果。此外,配体结合现在被认为是一个多步骤的过程,因为已经确定了细胞外区域的亚稳定和/或中间结合位点。在这篇综述中,我们总结了通过分子动力学(MD)分析的 G 蛋白偶联受体(GPCR)的实验配体结合数据及其结合途径。药物与 GPCR 结合的动力学较为复杂,取决于几个因素,包括受体表面的电荷分布、结合通道和结合点的配体-受体相互作用,或溶剂化作用。